Nechiporenko N A, STrotskiĭ A V
Vopr Onkol. 1996;42(4):66-8.
The term "locally advanced cancer of the urinary bladder" is discussed. The data on examination and treatment of 375 patients are presented to work out criteria of diagnosis of the disease. Such patients have been shown to reveal extensive lesions from bladder tumor coupled with such homeostatic disorders as hypoamino-acidemia, endotoxicosis, metabolic acidosis, immunity deficiency and disturbed hemoglobin-mediated transport of oxygen. Early postoperative complication incidence can be cut by 30-47% and 3-year survival after cystectomy-increased by 19% provided said homeostatic disturbances are corrected and immuno- and biostimulation is carried out. The best results in the treatment of locally advanced urinary bladder cancer (T2(m)N0M0) were recorded among cases of organ-saving therapy-65-70% have survived 5 years. Only 36.4% of patients with tumor (T3abN0M0) who received complex treatment (cystectomy + preoperative homeostatic correction) have survived 5 years. None of the patients with tumor (T4N0M0) has survived 3 years; therefore, only radiation and chemotherapy should be recommended in such cases.
本文讨论了“膀胱局部晚期癌”这一术语。展示了375例患者的检查和治疗数据,以制定该疾病的诊断标准。已证实这类患者存在膀胱肿瘤的广泛病变,并伴有诸如低氨基酸血症、内毒素血症、代谢性酸中毒、免疫缺陷以及血红蛋白介导的氧运输紊乱等内环境稳态失调。如果纠正上述内环境紊乱并进行免疫和生物刺激,术后早期并发症发生率可降低30 - 47%,膀胱切除术后3年生存率可提高19%。在保器官治疗的病例中,膀胱局部晚期癌(T2(m)N0M0)的治疗取得了最佳效果——65 - 70%的患者存活了5年。接受综合治疗(膀胱切除术 + 术前内环境稳态纠正)的肿瘤(T3abN0M0)患者中,只有36.4%存活了5年。肿瘤(T4N0M0)患者无一存活3年;因此,在这种情况下仅应推荐放疗和化疗。